Then, a binary logistic regression model was constructed based on the selected biomarker panel (PLA2G4F/PPARGC1A, ACOT6/HMGCLL1 and CYP2C8/SCP2) for the measurement of their importance for HCC clinical management. This evidence concerns the gene PPARGC1A and hepatocellular carcinoma.